Comparative Study of Elisa and Iift in Detecting Chlamydia Pneumoniae Specific Igg Antibodies in Patients of Acute Coronary Syndrome (ACS)
Keywords:
Enzyme Linked Immunosorbant Assay, Indirect Immunofluorescent Test, Chlamydia pneumonia, Acute Coronary SyndromeAbstract
Background: Chlamydia pnaumoniae is reported to be associated with coronary heart disease (CHD). Efficacy of available serologic tests for detecting C.pneumoniae antibodies has been debated. The aim of present study was to compare Enzyme Linked Immunosorbant Assay (ELISA) and Indirect Immunofluorescent Test (IIFT) for detecting specific antichlamydial antibodies in patients of Acute Coronary Syndrome (ACS).
Materials and Methods: Serum samples from 100 patients of ACS and 90 healthy controls were tested for the presence of Chlamydial IgG antibodies using ELISA and IIFT. To assess agreement between ELISA and IIFT, we used ‘nominal scale variables”. Agreement analysis was done using sensitivity, specificity, positive and negative predictive values (PPV and NPV) and diagnostic accuracy of the test.
Results: The ELISA and IIFT detected C.pneumoniae IgG antibodies in 66% and 48% respectively in patients of ACS, and 29% and 20% respectively of healthy controls. In patients of ACS, sensitivity and specificity of ELISA as compared to IIFT were 70.8% and 38.4% respectively. The PPV of ELISA for C.pneumoniae was 51.5% and NPV was 58.8%. The diagnostic accuracy of ELISA for C.pneumoniae was 54.6%. The two tests correlated in 54% of samples with a moderate agreement of =0.51.
Conclusions: The results of present study indicate that ELISA test was inferior to IIFT in detecting C.pneumoniae antibodies in patients of ACS.
References
Gupta S, Leatham EW, Carrington et al. Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction. Circulation 1997; 96: 404-407.
Boman J, Hammerschlag MR. Chlamydia pneumoniae and atherosclerosis: critical assessment of diagnostic methods and relevance to treatment studies. Clinical Microbiology Reviews 2002; 15 : 1-20.
Dowell SF, Boman GM, Carlone B et al. Standardizing Chlamydia pneumoniae assays: recommendations from the centers for Disease Control and Prevention (USA), and the Laboratory Centers for Disease Control (Canada). Clin Infect Dis. 2001; 33: 492-503.
Hermann C, Graf K, Straube E, Hartung T. Comparison of eleven commercial tests for CHlamydia pneumonia- specific immunoglobulin IgG in asymptomatic healthy individuals. J Clin Microbiol 2002; 40: 1603-9.
Schumacher A, Lerkerod AB, Seljeflot I et al. Chlamydia pneumoniae serology: Importance of methodology in patients with coronary heart disease and healthy individuals. J Clin Microbiol. 2001; 39: 1859-1864.
Pearson TA, Mensah GA, Alexander RW et al. Markers of inflammation and cardiovascular diseases : application to clinical and public health practice: a statement for health care professional from the centers for diseases control and prevention and American Heart Association. Circulation 2003: 107: 499-511.
Ofla FG, Gdoura R, Znazen A, Arab NB, Gargouri J et al. Evaluation and optimization of a commercial enzyme linked immunosorbant assay for detection of Chlamydophila pneumonia IgA antibodies. BMC Infectious Diseases 2008; 8: 98-105.
Miglani S, Gupta OP, Narang P. Infections and atherosclerosis: focus on Chlamydia pneumoniae and Helicobacter pylori. Abstract published in J Assoc Physicians India, 2002; 50: 61-62.
Choudhary DR, Kothari D, Lakhotia M, Ujjawal JS. Chlamydia pneumoniae antibody response in patients with acute myocardial infarction. Abstract published in J Assoc Physicians India, 2002; 50: 102.
Rajasekhar D, Subramanyam G, Latheef SAA, Vanajakshamma V, Srilatha A, Chaudhury A. Infectious etiology in acute coronary syndromes. Indian Jr Med Microbiol 2002: 20: 83-87.
Chaudhury A, Rajasekhar D, Latheef SAA, Subramanyam G, Seroprevalence of IgG antibodies to Chlamydia pneumoniae and Helicobactor pylori among coronary heart disease patients and normal individuals in South Indian population, Indian J Pathol Microbiol 2004: 47: 433-434.
Satpathy G, Sharma A, Vashisht S. Immunocomb Chlamydia bivalent assay to study Chlamydia species specific antibodies in patients with coronary artery disease. Indian J Med Res 2005; 121: 171-175.
Landis JR, Koch GG. An application of hierarchical kappa-type statistics in the assessment of majority agreement among multiple observers. Biometrics 1977; 33: 363-374.
Saikku P, Leinonen M, Mattila K et al. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary hart disease and acute myocardial infarction. Lancet 1988; 2: 983-986.
Libby P, Egan D, Skarlator S. Roles of infectious agents in atherosclerosis and restenosis. Circulation 1997; 336: 973-979.
Davidson M, Kuo CC, Midaugh JP et al. Confirmed previous infection with Chlamydia pneumoniae (TWAR) and its presence in early coronary atherosclerosis. Circulation. 1998; 98: 628-633.
Ridker PM, Kundsin RB, Stampfer MJ et al. Prospective study of Chlamydia pneumoniae IgG seropositivity and risks of future myocardial infarction. Circulation. 1999; 99: 1161-1164.
Wald NJ, Law MR, Morris JK et al. Chlamydia pneumoniae infection and mortality from ischaemic heart disease: large prospective study. BMJ. 2000; 321: 204-207.
Siscovick DS, Schwartz SM, Corey L et al. Chlamydia pneumoniae, Herpes simplex virus type I, and Cytomegalovirus and incident myocardial infarction and coronary heart disease death in older adults: the cardiovascular health study. Circulation. 2000; 102: 2335-2340.
Danesh J, Whincup P, Walker M et al. Chlamydia pneumoniae IgG titers and coronary heart disease: prospective study and metaanalysis. BMJ. 2000; 321: 208-213.
Bennedsen M, Berthelsen L, Lind I and the Infection, Atherosclerosis and Macrolide Antibiotics group. Performance of three micrommunofluorescence asays for detection of Chlamydia pneumonia immunoglobulin M, G and A antibodies. Clinical and DIagnostic Laboratoy Immunology, 2002; 9: 833-9.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
The authors retain the copyright of their article, with first publication rights granted to Medsci Publications.
